miR-107 orchestrates ER stress induction and lipid accumulation by post-transcriptional regulation of fatty acid synthase in hepatocytes

H Bhatia, G Verma, M Datta - Biochimica et Biophysica Acta (BBA)-Gene …, 2014 - Elsevier
MicroRNAs, a class of small non-coding RNAs, are believed to regulate several biological
pathways and processes and are implicated in several diseases. They mostly regulate the …

miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1

Y Guo, J Yu, C Wang, K Li, B Liu, Y Du… - Journal of …, 2017 - jme.bioscientifica.com
MicroRNAs, a class of small noncoding RNAs, are implicated in controlling a variety of
biological processes. We have shown that leucine deprivation suppresses lipogenesis by …

Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivo

H Bhatia, BR Pattnaik, M Datta - International journal of obesity, 2016 - nature.com
Background: Hepatic expression of microRNA-107 is ubiquitously upregulated in various
metabolic diseases. In our previous study, we had demonstrated that fatty acid synthase …

High fat diet induced downregulation of microRNA-467b increased lipoprotein lipase in hepatic steatosis

J Ahn, H Lee, CH Chung, T Ha - Biochemical and biophysical research …, 2011 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic fat accumulation and is
presently the most common chronic liver disease. However, the mechanisms underlying the …

[HTML][HTML] MicroRNA-199a-3p attenuates hepatic lipogenesis by targeting Sp1

Y Cheng, L Huang, J Ping, T Chen… - American Journal of …, 2017 - ncbi.nlm.nih.gov
Emerging studies have demonstrated that microRNAs (miRs) are profoundly involved in non-
alcoholic fatty liver disease (NAFLD) and related metabolic diseases. Previously, we …

[HTML][HTML] MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease

XC Wang, XR Zhan, XY Li, JJ Yu… - World journal of …, 2014 - ncbi.nlm.nih.gov
AIM: To assess the regulatory effect of microRNA-185 (miR-185) on lipid metabolism and the
insulin signalling pathway in human HepG2 hepatocytes and a high-fat diet mouse model …

Liver microRNA-291b-3p promotes hepatic lipogenesis through negative regulation of adenosine 5′-monophosphate (AMP)-activated protein kinase α1

X Meng, J Guo, W Fang, L Dou, M Li, X Huang… - Journal of Biological …, 2016 - ASBMB
In a microarray study, we found that hepatic miR-291b-3p was significantly increased in
leptin-receptor-deficient type 2 mice (db/db), a mouse model of diabetes. The function of miR …

miR-1224-5p Enhances Hepatic Lipogenesis by Targeting Adenosine Monophosphate–Activated Protein Kinase α1 in Male Mice

T Chen, D Yan, X Cheng, XJ Ji, J Bian, W Yin - Endocrinology, 2018 - academic.oup.com
MicroRNAs are potential therapeutic targets for metabolic diseases. Here, miR-1224-5p was
highly expressed in the livers of mice fed a high-fat diet (HFD) and in obese (ob/ob) mice. To …

[HTML][HTML] Emerging role of microRNAs in lipid metabolism

Z Yang, T Cappello, L Wang - Acta Pharmaceutica Sinica B, 2015 - Elsevier
Abstract microRNAs (miRNAs or miRs) are small non-coding RNAs that are involved in post-
transcriptional regulation of their target genes in a sequence-specific manner. Emerging …

[HTML][HTML] MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR

H Nie, C Song, D Wang, S Cui, T Ren, Z Cao… - … et Biophysica Acta (BBA …, 2017 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) affects obesity-associated metabolic syndrome,
which exhibits hepatic steatosis, insulin insensitivity and glucose intolerance. Previous …